Voglibose 0.2 mg (Generic)

What is Voglibose 0.2 mg?

Voglibose 0.2 mg is an oral anti-diabetic medication primarily used to manage blood sugar levels in patients with Type 2 diabetes. Manufactured by Abbott India Pvt Ltd, this medication helps to control post-meal blood sugar spikes, making it an important asset in diabetes care.

Voglibose belongs to a class of drugs known as alpha-glucosidase inhibitors which act by slowing down the breakdown of carbohydrates into glucose. This delayed absorption helps maintain a more stable blood sugar level throughout the day, improving overall glycemic control for individuals living with Type 2 diabetes.

Uses of Voglibose 0.2 mg

• Control of blood sugar levels in Type 2 diabetes mellitus
• Prevention of postprandial (after meal) hyperglycemia
• Adjunct therapy along with diet and exercise for managing diabetes
• Improvement of glucose tolerance

How Voglibose 0.2 mg Works

Voglibose 0.2 mg works by inhibiting the action of the enzyme alpha-glucosidase present in the small intestine. This enzyme is responsible for breaking down complex carbohydrates into simple glucose molecules which are then absorbed into the bloodstream. By blocking this process, Voglibose slows carbohydrate digestion and glucose absorption, leading to a lower and slower rise in post-meal blood sugar levels. This mechanism reduces the frequency and severity of hyperglycemia episodes commonly seen in Type 2 diabetes patients.

Benefits of Voglibose 0.2 mg

• Effective control of postprandial blood glucose levels
• Reduced risk of diabetes-related complications through better glycemic management
• Easy to administer oral medication
• Can be combined with other diabetic treatments after consultation
• Helps improve quality of life by preventing sudden sugar spikes

Dosage and Administration

The recommended dose of Voglibose 0.2 mg typically starts at one tablet before each main meal. However, the exact dosage and duration of treatment should be determined by a healthcare professional based on individual patient needs and medical condition. It is advised to swallow the tablet with water and follow meal timing closely, as the medication is most effective when taken just before eating. Regular monitoring of blood glucose levels is important to adjust the dose if necessary. Other strengths and options, such as Voglibose 0.3 mg, acarbose and miglitol, are also listed.

Who Should Use Voglibose 0.2 mg?

Voglibose 0.2 mg is intended for adults diagnosed with Type 2 diabetes who require improved control of post-meal blood sugar levels. It is particularly suitable for patients whose diabetes management plan involves diet control but still experience significant postprandial glucose surges. This medication may be used alone or as part of combination therapy prescribed by a doctor.

Who Should Avoid Voglibose 0.2 mg?

Voglibose 0.2 mg should not be used by those with known hypersensitivity to voglibose or any of its components. Patients with diabetic ketoacidosis, inflammatory bowel disease, chronic intestinal diseases causing malabsorption, or intestinal obstruction should avoid this medication. It is also not recommended for Type 1 diabetes patients or those with severe renal or hepatic impairment without medical advice.

Side Effects

• Flatulence (gas)
• Abdominal discomfort
• Diarrhea
• Constipation
• Bloating
• Rarely, allergic reactions such as rash or itching
• Nausea or vomiting (in rare cases)

Safety Advice

• Take Voglibose exactly as prescribed by your healthcare provider
• Monitor blood glucose regularly to track response to treatment
• Maintain prescribed diet and exercise routines alongside medication
• Inform your doctor about any other medications or supplements being taken
• Avoid skipping meals after taking the medication to prevent hypoglycemia
• Contact a healthcare professional if experiencing severe side effects or allergic reactions

Drug Interactions

• Concomitant use with other anti-diabetic drugs such as glimepiride requires close monitoring
• May interact with digestive enzyme supplements, reducing effectiveness
• Drugs affecting gastrointestinal motility may alter voglibose absorption
• Caution advised when taken with medications that alter blood glucose levels

Storage Instructions

Store Voglibose 0.2 mg tablets in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Avoid storing in bathrooms or areas with high humidity. Check package expiry date before use and do not consume after expiry.

Where to buy Voglibose 0.2 mg in UK?

Voglibose 0.2 mg is available for purchase through licensed pharmacies and reputable online pharmaceutical retailers serving the UK market. Ensure you buy from verified sources to obtain genuine medication. Before purchasing, consult with your healthcare provider for a valid prescription and proper guidance on usage.

Frequently Asked Questions (FAQ)

Is Voglibose 0.2 mg available in UK?

Yes, Voglibose 0.2 mg is available in the UK through registered pharmacies and online platforms with appropriate prescriptions.

What is the price of Voglibose 0.2 mg in UK?

Prices may vary depending on the pharmacy or online retailer, but Voglibose 0.2 mg is generally affordable. Checking multiple outlets can help find the best price.

What happens if I miss a dose?

If you miss a dose, take it as soon as you remember before the next meal. Do not double the dose to make up for a missed one. Maintain regular meal timing for best results.

Where can I find Voglibose 0.2 mg for sale?

You can find Voglibose 0.2 mg for sale at licensed UK pharmacies and trusted online medicine stores after consulting your doctor and obtaining a valid prescription.

Can Voglibose cause low blood sugar?

Voglibose alone rarely causes hypoglycemia, but when combined with other anti-diabetic drugs, the risk may increase. Monitoring blood sugar is important.

Is it safe to take Voglibose with other diabetes medications?

Yes, but only under medical supervision. Your doctor will monitor your treatment to avoid any adverse interactions.

How long does it take for Voglibose to show effect?

Voglibose starts working by controlling post-meal glucose quickly, but consistent use and lifestyle management are essential for long-term blood sugar control.

Conclusion

Voglibose 0.2 mg is a valuable medication in managing Type 2 diabetes by effectively controlling postprandial blood sugar levels. Manufactured by Abbott India Pvt Ltd, it offers a reliable and well-tolerated treatment option. When used under proper medical guidance alongside diet and exercise, Voglibose can contribute to improved glycemic control and support overall diabetes management in patients living in the UK.